Objective. To study the possible contribution of fluorodeoxyglucose (FDG)-positron emission tomography (PET ) in the diagnosis of giant cell arteritis and polymyalgia rheumatica.
Polymyalgia rheumatica is a clinical syndrome of proxin vivo measurement of metabolic processes possible. FDG is a glucose analogue which is transported across imal muscle pain and stiffness in older patients without pathognomonic diagnostic tests [1] [2] [3] . It is closely the capillary and sarcolemmal membranes in proportion to the rate of glucose uptake. Increased FDG uptake related to arteritis temporalis and many patients with this type of vasculitis have polymyalgia-like complaints.
can be observed in various conditions such as ischaemically threatened myocardial tissue [8] , cancer Polymyalgia rheumatica is diagnosed by exclusion of other disorders which can give rise to similar complaints [9] or inflammatory processes [10] . Since polymyalgia rheumatica and temporal arteritis are characterized by and by the rapid relief of symptoms by low-dose corticosteroid treatment.
impressive laboratory signs of inflammation, we evaluated the use of FDG-PET in these conditions. Except for surgical biopsy, arteriography, von Willebrand's factor antigen and anti-neutrophilic cytoplasmic antibody measurement [4] , no non-invasive Methods techniques are available for diagnosing vasculitis. Imaging techniques such as gallium scintigraphy [5] , Patients indium-labelled leucocyte scans [6 ] and three-phase All patients with giant cell arteritis or with a clinical Tc-99m pyrophosphate scintigraphy [7] have been used syndrome of polymyalgia rheumatica who were admitted in selected patients with vasculitis, yet inflamed vessels to the General Internal Medicine Department of the have never been visualized with these techniques.
University Hospital Gasthuisberg in Leuven, Belgium, Positron emission tomography (PET ) with radiobetween April 1996 and June 1998, underwent a FDGactive labelled fluoro-18-deoxyglucose ( FDG) makes PET scan. Diagnosis of giant cell arteritis was established when temporal artery biopsy revealed vasculitis in patients who fulfilled ACR criteria for this form of and Healey criteria for polymyalgia [2, 3] and when a temporal artery biopsy was normal. Patients who were monocytic leukaemia, infectious arthritis, systemic lupus erythematosus, rheumatoid arthritis, cytomegalovirus already treated with corticosteroids were excluded from the study. The control group consisted of patients, 50 yr infection and encephalitis in one patient each. of age or older, admitted during the same time period FDG-PET results with a long-lasting fever or an inflammatory syndrome which could not be ascribed to vasculitis. Table 1 summarizes the findings of vascular FDG uptake in the upper and lower legs, and in the thoracic arteries.
FDG imaging
An example of a normal FDG-PET scan and a FDGPatients fasted for at least 6 h before the examination.
PET scan in giant cell arteritis is given in Figs 1 and 2, Whole-body images were obtained using a CTI-Siemens respectively. 931/08/12 scanner, with an axial field of view of 10.1 cm.
Only one patient with giant cell arteritis had no A total of 6.5 Mbq/kg were injected i.v., 1 h before the increased vascular FDG uptake. The sole polymyalgia start of the acquisition. Whole-body imaging was perpatient without vascular FDG uptake had a much lower formed using 5 min/bed position for head, thorax and C-reactive protein concentration compared to the four abdomen, and 4 min/bed position for the lower extremitpatients with strong vascular FDG uptake (27 mg/l vs ies. Total acquisition time was~90 min.
122 ± 39 mg/l ). PET results were examined by two teams of two
In four of these five polymyalgia patients, a control nuclear medicine specialists who were not aware of the PET scan was performed during steroid treatment, at a diagnosis in these patients. Their results were compared time when inflammatory parameters had normalized and, if deviating, a consensus was reached after discusand patients had become asymptomatic. Vascular FDG sion. The blood vessels of the lower legs (tibial arteries), uptake had clearly decreased at that time (Fig. 3) . the upper legs (femoral and popliteal arteries) and the In control patients, increased FDG uptake in the thoracic arteries (aorta, subclavian arteries, carotid upper legs was seen in eight cases. Six of these eight arteries) were individually assessed. A zero score meant patients also displayed increased FDG uptake in the that there was absolutely no visualization of blood vessels of the lower legs. In one of these patients (a vessels, a score of 1 stood for minimal FDG uptake in 55-yr-old man with pneumonia), there was increased the vessels, at score 2 there was a clearly increased FDG uptake in the thoracic arteries as well. Only two vascular FDG uptake and at score 3 FDG uptake in of these eight patients had evidence of atherosclerosis; the vasculature was markedly pronounced. Scores 0 and the only patient with temporal arteritis and negative 1 were regarded as negative, scores 2 and 3 as positive.
FDG-PET, in contrast, suffered from pronounced atherosclerosis. Statistics Vascular FDG uptake in patients was compared with Discussion controls using x2 testing. Bonferroni correction was used when polymyalgia patients and giant cell arteritis
We have evaluated the possible role of FDG-PET in the patients as separate groups were compared with condiagnosis of giant cell arteritis and polymyalgia rheumtrols. Numerical data are followed by the standard atica. We could demonstrate that these patients have an deviation, whenever applicable.
increased FDG uptake in their larger thoracic arteries. This pattern was seen only once in the control group. Owing to high uptake in the brain, the small diameter Results of the vessel and the relatively high background of the Patients skin, direct evaluation of the temporal arteries is not possible on whole-body PET investigation. The high A total of 34 patients were included in the study. Six patients (three males, three females, mean age 70 ± 6 yr) uptake in the brain also prevents judging of the brain arteries. FDG uptake in the arteries of the upper and had giant cell arteritis. Five patients (all female) had a clinical diagnosis of polymyalgia rheumatica, their mean lower legs was less specific, since these features were found in 35 and 26%, respectively, of the control populaage was 63 ± 6 yr. There were no clinical signs of temporal artery involvement in these polymyalgia tion as well. We speculate that atherosclerosis might also contribute to an increased FDG uptake by the patients (no jaw claudication, no headache, no visual disturbances). vessels, particularly in the light of recent findings suggesting an important inflammatory component in the In 23 patients (17 male, six female, mean age 65 ± 10 yr), the fever and/or inflammation was not due pathogenesis of atherosclerosis [12, 13] . However, the abdominal aorta or the iliac arteries, which are freto vasculitis or polymyalgia. In 10 patients, no explanation for the fever or inflammatory syndrome was found, quently involved in atherosclerosis in an older population, were never visualized on FDG-PET scan. The but in seven of them there was a spontaneous recovery, which makes a transient infectious cause plausible. The single control patient with increased thoracic FDG uptake had no striking signs of atherosclerosis. This was following diagnoses were made in the remaining 13 cases: tuberculosis and sarcoidosis in two patients each, also the case in five other patients with increased vascular FDG uptake in the legs. In contrast, the single patient and monoclonal gammapathy of unknown significance, chronic pyelonephritis, bronchiectasias, chronic myelowith giant cell arteritis who had no increased vascular local hot spots, corresponding to inflammatory plaques, rather than the smooth, linear picture found in the temporal arteritis and polymyalgia patients (Figs 2 and  3a) . The normalization of FDG uptake in the subclavian arteries in patients with polymyalgia rheumatica during steroid therapy strongly argues against atherosclerosis as a cause of increased FDG uptake. Therefore, we believe that the increased FDG uptake in the thoracic blood vessels of our patients is truly due to inflammation, namely vasculitis. This suggests that polymyalgia is, in fact, a manifestation of an underlying vasculitic process, as has already been suggested by Weyand et al. [14, 15] . These authors found very similar levels of mRNA for inflammatory cytokines in temporal artery biopsies of patients with giant cell arteritis and in patients with isolated polymyalgia, clearly different from patients without these diseases. Our findings suggest that FDG-PET scan, like measurement of mRNA for scopic examination of temporal artery biopsies. The 'whole-body' FDG-PET scan offers the extra FDG uptake suffered from marked atherosclerosis. In addition, if atherosclerosis were to give rise to increased advantage that all foci of vasculitis are visualized with one examination. The increased FDG uptake in the FDG uptake in the vessel wall, we would expect to find ment with sulfamethoxazole/trimethoprim. Am J Med aorta, the subclavian arteries and the arteries of the 
